Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / App Notes / 2019 / Assessment of the performance of a hybridisation-based NGS enrichment panel with as little as 10 ng of severely formalin-compromised DNA

Assessment of the performance of a hybridisation-based NGS enrichment panel with as little as 10 ng of severely formalin-compromised DNA

05/08/2019

Share

Jacqueline Chan, Juliette Forster, Aysel Heckel, Venu Pullabhatla, Dave Cook, Graham Speight
Oxford Gene Technology (OGT)

Introduction

Formalin-fixed, paraffin-embedded (FFPE) storage is a standard method for archiving samples from solid tumours. It ensures the preservation of the ultrastructure of tissues and prevents degradation through formation of chemical links between macromolecules, for example between and within DNA molecules. FFPE samples contain a wealth of information which can be used to study cancer development and progression. Next generation sequencing (NGS) offers the capability of unlocking this information through the simultaneous study of multiple types of mutations in cancer-associated genes for a number of applications1. However, formalin treatment can significantly compromise the quality and amount of nucleic acids available for genomics research. As such it is technically challenging to examine the true genetic complexity present in a sample.

In this study DNA reference standards with different levels of formalin-induced damage were hybridised and sequenced with a SureSeqTM custom NGS panel in conjunction with the SureSeq FFPE DNA Repair Mix*. We assessed the impact of the repair mix on three levels of formalin compromised DNA (fcDNA) - ‘mild’, ‘moderate’ and ‘severe’, at 4 different DNA input amounts down to 10 ng. We then compared the uniformity and coverage of the enriched targets. We also assessed the concordance to the allele frequencies of the variants in the reference standards.

Study design

We tested three reference standards of fcDNA (provided by Horizon Discovery†) with ‘mild’, ‘moderate’ and ‘severe’ damage2. The samples were investigated in duplicate before and after repair with SureSeq FFPE DNA Repair mix; the amounts of input DNA were 200, 100, 50 and 10 ng (Figure 1). All samples were sheared using a Covaris S220 focused-ultrasonicator and prepared using the SureSeq NGS Library Preparation Kit (cat. no. 500070).

Enrichment by hybridisation was completed with a SureSeq custom NGS 8.7 Kb custom hot-spot panel designed to target the variants present in the reference standards (see Table 1 for variants targeted). The subsequent post-capture libraries were sequenced on an Illumina MiSeq® using a v2 300 cycles kit (cat. no. MS-102-2002). 16 samples were run on a MiSeq lane.

>> Download the poster as PDF

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Oncomine Dx Target Test – an IVD NGS solution for every lab

February 20, 2019

What to Consider When Choosing a Microscope Camera

March 5, 2019

Comparison of cfDNA Reference Material Prepared using Enzymatic Fragmentation or Sonication for the Validation of Liquid Biopsy Assays

May 28, 2019

Rapid, High-Performance Tumor Profiling Using CleanPlex® OncoZoom® Cancer Hotspot Panel and SOPHiA™ AI

April 18, 2019

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.